Nomura (NYSE:NMR) Hits New 1-Year High at $4.96

Share on StockTwits

Nomura Holdings Inc (NYSE:NMR)’s stock price hit a new 52-week high on Tuesday . The company traded as high as $4.96 and last traded at $4.96, with a volume of 700 shares. The stock had previously closed at $4.90.

A number of analysts recently weighed in on the stock. JPMorgan Chase & Co. upgraded shares of Nomura from an “underweight” rating to a “neutral” rating in a report on Wednesday, July 31st. Nomura raised shares of Nomura from an “underweight” rating to a “neutral” rating in a research note on Wednesday, July 31st. Zacks Investment Research raised shares of Nomura from a “sell” rating to a “hold” rating in a research note on Saturday, August 10th. ValuEngine lowered shares of Nomura from a “sell” rating to a “strong sell” rating in a research note on Friday, November 8th. Finally, TheStreet raised shares of Nomura from a “d” rating to a “c” rating in a research note on Wednesday, October 30th. Two equities research analysts have rated the stock with a sell rating and three have given a hold rating to the company. The stock presently has an average rating of “Hold”.

The business’s 50 day moving average is $4.57 and its 200 day moving average is $3.85. The company has a debt-to-equity ratio of 5.98, a quick ratio of 0.98 and a current ratio of 0.98. The stock has a market cap of $16.42 billion, a price-to-earnings ratio of -18.35 and a beta of 1.39.

Nomura (NYSE:NMR) last posted its quarterly earnings data on Tuesday, October 29th. The financial services provider reported $0.38 EPS for the quarter. Nomura had a net margin of 5.73% and a return on equity of 3.89%. The firm had revenue of $5.35 billion during the quarter. Research analysts expect that Nomura Holdings Inc will post 0.59 earnings per share for the current year.

Institutional investors have recently bought and sold shares of the stock. Campbell & CO Investment Adviser LLC purchased a new stake in Nomura in the 3rd quarter worth approximately $45,000. Pinnacle Wealth Planning Services Inc. purchased a new stake in Nomura in the 3rd quarter worth approximately $47,000. Creative Planning purchased a new stake in Nomura in the 3rd quarter worth approximately $50,000. A.R.T. Advisors LLC lifted its position in Nomura by 30.6% in the 2nd quarter. A.R.T. Advisors LLC now owns 13,708 shares of the financial services provider’s stock worth $49,000 after buying an additional 3,208 shares in the last quarter. Finally, Parallel Advisors LLC lifted its position in Nomura by 40.6% in the 2nd quarter. Parallel Advisors LLC now owns 14,052 shares of the financial services provider’s stock worth $50,000 after buying an additional 4,056 shares in the last quarter. 0.68% of the stock is owned by hedge funds and other institutional investors.

Nomura Company Profile (NYSE:NMR)

Nomura Holdings, Inc provides various financial services to individuals, corporations, financial institutions, governments, and governmental agencies worldwide. It operates through three segments: Retail, Asset Management, and Wholesale. The Retail segment offers various financial products and investment services for individuals and corporations.

Read More: Why do earnings reports matter?

Receive News & Ratings for Nomura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nomura and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Analysts Set $33.00 Target Price for SpringWorks Therapeutics
Analysts Set $33.00 Target Price for SpringWorks Therapeutics
Ardelyx Inc  Given Consensus Rating of “Hold” by Analysts
Ardelyx Inc Given Consensus Rating of “Hold” by Analysts
Western Midstream Partners LP  Receives $32.25 Consensus Price Target from Analysts
Western Midstream Partners LP Receives $32.25 Consensus Price Target from Analysts
SL Green Realty Corp  Receives $93.85 Average Price Target from Brokerages
SL Green Realty Corp Receives $93.85 Average Price Target from Brokerages
HC Wainwright Reaffirms Buy Rating for Y-mAbs Therapeutics
HC Wainwright Reaffirms Buy Rating for Y-mAbs Therapeutics
Analysts Set SS&C Technologies Holdings, Inc.  Price Target at $65.91
Analysts Set SS&C Technologies Holdings, Inc. Price Target at $65.91


© 2006-2019 Ticker Report